FHIR IG analytics| Package | hl7.fhir.uv.ebm |
| Resource Type | EvidenceVariable |
| Id | EvidenceVariable-367896.json |
| FHIR Version | R6 |
No resources found
No resources found
Note: links and images are rebased to the (stated) source
Generated Narrative: EvidenceVariable 367896
version: 26; Last updated: 2025-08-18 13:22:42+0000; Language: en
Profile: VariableDefinition
EvidenceVariableHandlingDetail: Evidence variable handling not specified
ArtifactPublicationStatus: Active
url: https://fevir.net/resources/EvidenceVariable/367896
identifier: FEvIR Object Identifier/367896, FEvIR Linking Identifier/NCT03640312-otherOutcome-0
name: Percentage_of_Participants_With_Serious_Adverse_Events_SAEs_NCT03640312
title: Percentage of Participants With Serious Adverse Events (SAEs) (NCT03640312)
citeAs:
Percentage of Participants With Serious Adverse Events (SAEs) (NCT03640312) [Database Entry: FHIR EvidenceVariable Resource]. Contributors: Computable Publishing®: ClinicalTrials.gov-to-FEvIR Converter [Authors/Creators]. In: Fast Evidence Interoperability Resources (FEvIR) Platform, FOI 367896. Revised 2025-08-18. Available at: https://fevir.net/resources/EvidenceVariable/367896. Computable resource at: https://fevir.net/resources/EvidenceVariable/367896#json.
status: Active
author: Computable Publishing®: ClinicalTrials.gov-to-FEvIR Converter:
publisher: Computable Publishing LLC
contact: support@computablepublishing.com
description:
Percentage of participants with any Serious Adverse Events (SAE) according to Good Clinical Practice definition: adverse events that result in death, are life threatening, require hospitalization or prolong existing hospitalization, result in persistent disability, result in congenital anomaly or birth defect, or unimportant medical event that requires intervention to prevent any of the above.
copyright:
https://creativecommons.org/licenses/by-nc-sa/4.0/
| Reference |
| Group: membership = conceptual |
handling: extension
Generated Narrative: Group #variable-definition
Profile: ConceptualCohortDefinition
membership: Conceptual
characteristic
code: defined by CodeableConcept
value: Percentage of Participants With Serious Adverse Events (SAEs)
exclude: false
Timings
Text 12 weeks
{
"resourceType": "EvidenceVariable",
"id": "367896",
"meta": {
"versionId": "26",
"lastUpdated": "2025-08-18T13:22:42.074Z",
"profile": [
"http://hl7.org/fhir/uv/ebm/StructureDefinition/variable-definition"
]
},
"language": "en",
"text": {
"status": "extensions",
"div": "<!-- snip (see above) -->"
},
"contained": [
{
"resourceType": "Group",
"id": "variable-definition",
"meta": {
"profile": [
"http://hl7.org/fhir/uv/ebm/StructureDefinition/conceptual-cohort-definition"
]
},
"membership": "conceptual",
"characteristic": [
{
"code": {
"text": "defined by CodeableConcept"
},
"valueCodeableConcept": {
"text": "Percentage of Participants With Serious Adverse Events (SAEs)"
},
"exclude": false,
"timing": [
{
"text": "12 weeks"
}
]
}
]
}
],
"extension": [
{
"url": "http://hl7.org/fhir/uv/ebm/StructureDefinition/evidence-variable-handling-detail",
"valueCodeableConcept": {
"coding": [
{
"system": "https://fevir.net/resources/CodeSystem/179423",
"code": "evidence-variable-handling-not-specified",
"display": "Evidence variable handling not specified"
}
]
}
},
{
"url": "http://hl7.org/fhir/uv/ebm/StructureDefinition/artifact-publication-status",
"valueCodeableConcept": {
"coding": [
{
"system": "http://terminology.hl7.org/CodeSystem/cited-artifact-status-type",
"code": "active",
"display": "Active"
}
]
}
}
],
"url": "https://fevir.net/resources/EvidenceVariable/367896",
"identifier": [
{
"type": {
"coding": [
{
"system": "http://terminology.hl7.org/CodeSystem/v2-0203",
"code": "ACSN",
"display": "Accession ID"
}
],
"text": "FEvIR Object Identifier"
},
"system": "https://fevir.net/FOI",
"value": "367896",
"assigner": {
"display": "Computable Publishing LLC"
}
},
{
"type": {
"text": "FEvIR Linking Identifier"
},
"system": "https://fevir.net/FLI",
"value": "NCT03640312-otherOutcome-0",
"assigner": {
"display": "Computable Publishing LLC"
}
}
],
"name": "Percentage_of_Participants_With_Serious_Adverse_Events_SAEs_NCT03640312",
"title": "Percentage of Participants With Serious Adverse Events (SAEs) (NCT03640312)",
"citeAs": "Percentage of Participants With Serious Adverse Events (SAEs) (NCT03640312) [Database Entry: FHIR EvidenceVariable Resource]. Contributors: Computable Publishing®: ClinicalTrials.gov-to-FEvIR Converter [Authors/Creators]. In: Fast Evidence Interoperability Resources (FEvIR) Platform, FOI 367896. Revised 2025-08-18. Available at: https://fevir.net/resources/EvidenceVariable/367896. Computable resource at: https://fevir.net/resources/EvidenceVariable/367896#json.",
"status": "active",
"author": [
{
"name": "Computable Publishing®: ClinicalTrials.gov-to-FEvIR Converter"
}
],
"publisher": "Computable Publishing LLC",
"contact": [
{
"telecom": [
{
"system": "email",
"value": "support@computablepublishing.com"
}
]
}
],
"description": "Percentage of participants with any Serious Adverse Events (SAE) according to Good Clinical Practice definition: adverse events that result in death, are life threatening, require hospitalization or prolong existing hospitalization, result in persistent disability, result in congenital anomaly or birth defect, or unimportant medical event that requires intervention to prevent any of the above.",
"copyright": "https://creativecommons.org/licenses/by-nc-sa/4.0/",
"definition": {
"reference": {
"reference": "#variable-definition",
"type": "Group"
}
},
"handling": "extension"
}